about
Why examining the desirability of health technology matters.Closing the regulatory regress: GMP accreditation in stem cell laboratories.Regulation of tissue-engineered products in the European Union: where are we heading?What Pacemakers Can Teach Us about the Ethics of Maintaining Artificial Organs.Tissue-Engineered Technologies: Scientific Biomedicine, Frames of Risk and Regulatory Regime-Building in EuropeCulturing Cells, Reproducing and Regulating the Self
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Human tissue engineered products--drugs or devices?
@en
Human tissue engineered products--drugs or devices?
@nl
type
label
Human tissue engineered products--drugs or devices?
@en
Human tissue engineered products--drugs or devices?
@nl
prefLabel
Human tissue engineered products--drugs or devices?
@en
Human tissue engineered products--drugs or devices?
@nl
P2093
P2860
P1433
P1476
Human tissue engineered products--drugs or devices?
@en
P2093
Alex Faulkner
David FitzPatrick
Ingrid Geesink
Julie Kent
P2860
P304
P356
10.1136/BMJ.326.7400.1159
P407
P577
2003-05-01T00:00:00Z